Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update
NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through ...
Orchestra BioMed Holdings, Inc.: Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact technologies ...
Yahoo Finance6h
Biomaterials Market to Reach USD 650.56 Billion by 2032, Driven by Technological Advancements and Rising Healthcare Demand
Austin, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The S&S Insider report indicates that, “The Biomaterials Market was valued at USD 178.08 billion in 2023 and is expected to reach USD 650.56 billion by 2032, ...